Yimei Wang, a 4th-year PhD candidate, is the Drug Metabolism and Disposition Highlighted Trainee Author for April 2026.

Her published research, “Design, Expression, Purification, and Application of Novel Recombinant miR-491 Agents to Study UGT1A Regulation,” utilizes in vivo fermentation with tRNA scaffold and tRNA-fused pre-miRNA carrier technologies to produce novel recombinant miRNA molecules. 

“I hope that my research advances the understanding of how miRNAs regulate drug metabolism and disposition by showcasing the effectiveness of novel recombinant miRNA agents as powerful tools for pharmacological studies,” she shares.